We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
+6.38%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$37.1B
AUM Growth
+$1.81B
(+5.1%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
8.75%
Holding
2,506
New
326
Increased
944
Reduced
921
Closed
286
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$297M |
| 2 |
CELG
Celgene Corp
CELG
|
+$277M |
| 3 |
US Bancorp
USB
|
+$190M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$259M |
| 2 |
DuPont de Nemours
DD
|
+$255M |
| 3 |
Boeing
BA
|
+$243M |
| 4 |
Altria Group
MO
|
+$234M |
| 5 |
Union Pacific
UNP
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.5% |
| 2 | Technology | 15.03% |
| 3 | Consumer Discretionary | 14.19% |
| 4 | Industrials | 12.34% |
| 5 | Consumer Staples | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MASI
426
DELISTED
Masimo
MASI
| $18.2M | 0.05% |
214,868
-292,747
| -58% | -$25.4M |
|
427
Haemonetics
HAE
$3.58B
| $18.2M | 0.05% |
313,305
+219,300
| +233% | +$11.5M |
|
428
HCA Healthcare
HCA
$84.8B
| $18.2M | 0.05% |
206,807
-39,000
| -16% | -$3.13M |
|
429
Hexcel
HXL
$8.32B
| $18.1M | 0.05% |
+293,125
| New | +$17.8M |
|
430
State Street Materials Select Sector SPDR ETF
XLB
$8.51B
| $18.1M | 0.05% |
599,000
-1,151,000
| -66% | -$33.9M |
|
431
Kinross Gold
KGC
$28.5B
| $18M | 0.05% |
4,168,139
+1,564,686
| +60% | +$6.52M |
|
432
CF Industries
CF
$19.2B
| $18M | 0.05% |
422,190
+266,400
| +171% | +$10.1M |
|
433
Fortune Brands Innovations
FBIN
$6.12B
| $17.9M | 0.05% |
306,507
+127,998
| +72% | +$7.27M |
|
434
First Solar
FSLR
$21.8B
| $17.9M | 0.05% |
265,202
-329,944
| -55% | -$19.4M |
|
435
Alkermes
ALKS
$8.82B
| $17.9M | 0.05% |
326,916
+151,281
| +86% | +$7.72M |
|
436
Aptiv
APTV
$12B
| $17.9M | 0.05% |
210,841
-120,067
| -36% | -$11.4M |
|
437
Prosperity Bancshares
PB
$8.77B
| $17.8M | 0.05% |
254,236
-130,985
| -34% | -$8.75M |
|
438
JetBlue
JBLU
$1.96B
| $17.4M | 0.05% |
781,012
+157,200
| +25% | +$3.21M |
|
439
iShares Russell Mid-Cap Growth ETF
IWP
$20B
| $17.4M | 0.05% |
288,600
+191,400
| +197% | +$11.2M |
|
|
HRC
440
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $17.3M | 0.05% |
+205,813
| New | +$16.7M |
|
|
PTLA
441
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $17.3M | 0.05% |
355,700
+162,800
| +84% | +$8.23M |
|
442
BCE
BCE
$19.9B
| $17.1M | 0.05% |
354,242
+2,700
| +0.8% | +$129K |
|
443
Nordson
NDSN
$16.5B
| $17M | 0.05% |
+116,360
| New | +$15M |
|
444
VanEck Semiconductor ETF
SMH
$67.6B
| $16.9M | 0.05% |
345,000
-269,200
| -44% | -$13.4M |
|
445
Pitney Bowes
PBI
$2.42B
| $16.8M | 0.05% |
1,502,957
+298,600
| +25% | +$3.52M |
|
446
Jacobs Solutions
J
$15.9B
| $16.8M | 0.05% |
307,427
-189,930
| -38% | -$9.74M |
|
447
HubSpot
HUBS
$10.5B
| $16.7M | 0.05% |
189,081
-76,300
| -29% | -$6.4M |
|
448
The Mosaic Company
MOS
$7.09B
| $16.7M | 0.05% |
651,310
-14,329
| -2% | -$329K |
|
449
CoreCivic
CXW
$3.1B
| $16.5M | 0.04% |
733,108
-112,924
| -13% | -$2.71M |
|
450
Coca-Cola Europacific Partners
CCEP
$46.5B
| $16.5M | 0.04% |
+413,169
| New | +$16.5M |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, Two Sigma Advisers held 2,506 positions worth $37.1B, up 5.1% from $35.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Two Sigma Advisers's Q4 2017 filing shows 326 new, 944 increased, 921 reduced and 286 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 381,038 shares worth $143M. The largest sale was Chevron, an estimated $259M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.
- Two Sigma Advisers's largest Q4 2017 buy was Regeneron Pharmaceuticals: 381,038 shares worth $143M.
- Two Sigma Advisers added most to PG&E in Q4 2017, an estimated $297M increase.
- Two Sigma Advisers's biggest Q4 2017 reduction was Chevron, cutting an estimated $259M.
- Two Sigma Advisers fully exited DuPont de Nemours in Q4 2017, selling an estimated $255M.
- Two Sigma Advisers's ten largest holdings make up 8.7% of its $37.1B portfolio in Q4 2017.
- Two Sigma Advisers opened 326 new positions and closed 286 in Q4 2017.
- Two Sigma Advisers's portfolio value rose 5.1% quarter-over-quarter to $37.1B.
Based on Two Sigma Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.